Carisma Therapeutics

company

Number of Lead Investors

Number of Investors

Carisma Therapeutics is funded by 15 investors. 4BIO Capital and AbbVie are the most recent investors.

Investor Name	Lead Investor	Funding Round
4BIO Capital	-	Series C
AbbVie	-	Series C
Agent Capital	-	Series C
HealthCap	-	Series C
Livzon Pharmaceutical Group	-	Series C
MRL Ventures Fund	-	Series C
Penn Medicine Co-Investment Program	-	Series C
Pictet Alternative Advisors	-	Series C
Solasta Ventures	-	Series C
SymBiosis LLC	-	Series C
TPG Biotech	-	Series C
Wellington Partners	-	Series C
AbbVie Biotech Ventures	-	Series B
IP Group	-	Series B
Grazia Equity	-	Series A